ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Antibiotic Resistance Biomarkers - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-0I2290
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Antibiotic Resistance Biomarkers Market Insights and Forecast to 2028
BUY CHAPTERS

Antibiotic Resistance Biomarkers - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-0I2290
Report
November 2024
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Thermo Fisher Scientific
Qiagen NV
Abbott
Bio Rad Laboratories
Cube Dx GmbH
Merck
Creative Diagnostic
Roche
HiMedia Laboratories
Danaher Corporatory
GenMark Diagnostic

Antibiotic Resistance Biomarkers - Market Size

The global market for Antibiotic Resistance Biomarkers was estimated to be worth US$ 3335.8 million in 2023 and is forecast to a readjusted size of US$ 4036.2 million by 2030 with a CAGR of 2.8% during the forecast period 2024-2030

Antibiotic Resistance Biomarkers - Market

Antibiotic Resistance Biomarkers - Market

Antibiotics are medicines used to prevent and treat bacterial infections. Antibiotic resistance occurs,when the medicines used to treat infections caused by bacteria no longer work.
North American market for Antibiotic Resistance Biomarkers was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Antibiotic Resistance Biomarkers was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Antibiotic Resistance Biomarkers was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Antibiotic Resistance Biomarkers include Thermo Fisher Scientific, Qiagen, Abbott, Bio-Rad Laboratories, Cube Dx GmbH, GenMark Diagnostic, Merck, Creative Diagnostic and Roche, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antibiotic Resistance Biomarkers, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Antibiotic Resistance Biomarkers by region & country, by Type, and by Application.
The Antibiotic Resistance Biomarkers market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibiotic Resistance Biomarkers.
Market Segmentation

Scope of Antibiotic Resistance Biomarkers - Market Report

Report Metric Details
Report Name Antibiotic Resistance Biomarkers - Market
Forecasted market size in 2030 US$ 4036.2 million
CAGR 2.8%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Qiagen, Abbott, Bio-Rad Laboratories, Cube Dx GmbH, GenMark Diagnostic, Merck, Creative Diagnostic, Roche, HiMedia Laboratories, Danaher Corporatory
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Antibiotic Resistance Biomarkers manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Antibiotic Resistance Biomarkers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Antibiotic Resistance Biomarkers in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Antibiotic Resistance Biomarkers - Market size in 2030?

Ans: The Antibiotic Resistance Biomarkers - Market size in 2030 will be US$ 4036.2 million.

Who are the main players in the Antibiotic Resistance Biomarkers - Market report?

Ans: The main players in the Antibiotic Resistance Biomarkers - Market are Thermo Fisher Scientific, Qiagen, Abbott, Bio-Rad Laboratories, Cube Dx GmbH, GenMark Diagnostic, Merck, Creative Diagnostic, Roche, HiMedia Laboratories, Danaher Corporatory

What are the Application segmentation covered in the Antibiotic Resistance Biomarkers - Market report?

Ans: The Applications covered in the Antibiotic Resistance Biomarkers - Market report are Diagnostics, Drug Discovery, Personalized Medicine, Others

What are the Type segmentation covered in the Antibiotic Resistance Biomarkers - Market report?

Ans: The Types covered in the Antibiotic Resistance Biomarkers - Market report are Blood Biomarkers, Urine Biomarkers

Recommended Reports

Antibiotic Resistance

Biomarker Technologies

Infectious Disease Diagnostics

1 Market Overview
1.1 Antibiotic Resistance Biomarkers Product Introduction
1.2 Global Antibiotic Resistance Biomarkers Market Size Forecast
1.3 Antibiotic Resistance Biomarkers Market Trends & Drivers
1.3.1 Antibiotic Resistance Biomarkers Industry Trends
1.3.2 Antibiotic Resistance Biomarkers Market Drivers & Opportunity
1.3.3 Antibiotic Resistance Biomarkers Market Challenges
1.3.4 Antibiotic Resistance Biomarkers Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antibiotic Resistance Biomarkers Players Revenue Ranking (2023)
2.2 Global Antibiotic Resistance Biomarkers Revenue by Company (2019-2024)
2.3 Key Companies Antibiotic Resistance Biomarkers Manufacturing Base Distribution and Headquarters
2.4 Key Companies Antibiotic Resistance Biomarkers Product Offered
2.5 Key Companies Time to Begin Mass Production of Antibiotic Resistance Biomarkers
2.6 Antibiotic Resistance Biomarkers Market Competitive Analysis
2.6.1 Antibiotic Resistance Biomarkers Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Antibiotic Resistance Biomarkers Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibiotic Resistance Biomarkers as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Blood Biomarkers
3.1.2 Urine Biomarkers
3.2 Global Antibiotic Resistance Biomarkers Sales Value by Type
3.2.1 Global Antibiotic Resistance Biomarkers Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Antibiotic Resistance Biomarkers Sales Value, by Type (2019-2030)
3.2.3 Global Antibiotic Resistance Biomarkers Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Diagnostics
4.1.2 Drug Discovery
4.1.3 Personalized Medicine
4.1.4 Others
4.2 Global Antibiotic Resistance Biomarkers Sales Value by Application
4.2.1 Global Antibiotic Resistance Biomarkers Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Antibiotic Resistance Biomarkers Sales Value, by Application (2019-2030)
4.2.3 Global Antibiotic Resistance Biomarkers Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Antibiotic Resistance Biomarkers Sales Value by Region
5.1.1 Global Antibiotic Resistance Biomarkers Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Antibiotic Resistance Biomarkers Sales Value by Region (2019-2024)
5.1.3 Global Antibiotic Resistance Biomarkers Sales Value by Region (2025-2030)
5.1.4 Global Antibiotic Resistance Biomarkers Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Antibiotic Resistance Biomarkers Sales Value, 2019-2030
5.2.2 North America Antibiotic Resistance Biomarkers Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Antibiotic Resistance Biomarkers Sales Value, 2019-2030
5.3.2 Europe Antibiotic Resistance Biomarkers Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Antibiotic Resistance Biomarkers Sales Value, 2019-2030
5.4.2 Asia Pacific Antibiotic Resistance Biomarkers Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Antibiotic Resistance Biomarkers Sales Value, 2019-2030
5.5.2 South America Antibiotic Resistance Biomarkers Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Antibiotic Resistance Biomarkers Sales Value, 2019-2030
5.6.2 Middle East & Africa Antibiotic Resistance Biomarkers Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Antibiotic Resistance Biomarkers Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Antibiotic Resistance Biomarkers Sales Value
6.3 United States
6.3.1 United States Antibiotic Resistance Biomarkers Sales Value, 2019-2030
6.3.2 United States Antibiotic Resistance Biomarkers Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Antibiotic Resistance Biomarkers Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Antibiotic Resistance Biomarkers Sales Value, 2019-2030
6.4.2 Europe Antibiotic Resistance Biomarkers Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Antibiotic Resistance Biomarkers Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Antibiotic Resistance Biomarkers Sales Value, 2019-2030
6.5.2 China Antibiotic Resistance Biomarkers Sales Value by Type (%), 2023 VS 2030
6.5.3 China Antibiotic Resistance Biomarkers Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Antibiotic Resistance Biomarkers Sales Value, 2019-2030
6.6.2 Japan Antibiotic Resistance Biomarkers Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Antibiotic Resistance Biomarkers Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Antibiotic Resistance Biomarkers Sales Value, 2019-2030
6.7.2 South Korea Antibiotic Resistance Biomarkers Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Antibiotic Resistance Biomarkers Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Antibiotic Resistance Biomarkers Sales Value, 2019-2030
6.8.2 Southeast Asia Antibiotic Resistance Biomarkers Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Antibiotic Resistance Biomarkers Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Antibiotic Resistance Biomarkers Sales Value, 2019-2030
6.9.2 India Antibiotic Resistance Biomarkers Sales Value by Type (%), 2023 VS 2030
6.9.3 India Antibiotic Resistance Biomarkers Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific Antibiotic Resistance Biomarkers Products, Services and Solutions
7.1.4 Thermo Fisher Scientific Antibiotic Resistance Biomarkers Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Qiagen
7.2.1 Qiagen Profile
7.2.2 Qiagen Main Business
7.2.3 Qiagen Antibiotic Resistance Biomarkers Products, Services and Solutions
7.2.4 Qiagen Antibiotic Resistance Biomarkers Revenue (US$ Million) & (2019-2024)
7.2.5 Qiagen Recent Developments
7.3 Abbott
7.3.1 Abbott Profile
7.3.2 Abbott Main Business
7.3.3 Abbott Antibiotic Resistance Biomarkers Products, Services and Solutions
7.3.4 Abbott Antibiotic Resistance Biomarkers Revenue (US$ Million) & (2019-2024)
7.3.5 Bio-Rad Laboratories Recent Developments
7.4 Bio-Rad Laboratories
7.4.1 Bio-Rad Laboratories Profile
7.4.2 Bio-Rad Laboratories Main Business
7.4.3 Bio-Rad Laboratories Antibiotic Resistance Biomarkers Products, Services and Solutions
7.4.4 Bio-Rad Laboratories Antibiotic Resistance Biomarkers Revenue (US$ Million) & (2019-2024)
7.4.5 Bio-Rad Laboratories Recent Developments
7.5 Cube Dx GmbH
7.5.1 Cube Dx GmbH Profile
7.5.2 Cube Dx GmbH Main Business
7.5.3 Cube Dx GmbH Antibiotic Resistance Biomarkers Products, Services and Solutions
7.5.4 Cube Dx GmbH Antibiotic Resistance Biomarkers Revenue (US$ Million) & (2019-2024)
7.5.5 Cube Dx GmbH Recent Developments
7.6 GenMark Diagnostic
7.6.1 GenMark Diagnostic Profile
7.6.2 GenMark Diagnostic Main Business
7.6.3 GenMark Diagnostic Antibiotic Resistance Biomarkers Products, Services and Solutions
7.6.4 GenMark Diagnostic Antibiotic Resistance Biomarkers Revenue (US$ Million) & (2019-2024)
7.6.5 GenMark Diagnostic Recent Developments
7.7 Merck
7.7.1 Merck Profile
7.7.2 Merck Main Business
7.7.3 Merck Antibiotic Resistance Biomarkers Products, Services and Solutions
7.7.4 Merck Antibiotic Resistance Biomarkers Revenue (US$ Million) & (2019-2024)
7.7.5 Merck Recent Developments
7.8 Creative Diagnostic
7.8.1 Creative Diagnostic Profile
7.8.2 Creative Diagnostic Main Business
7.8.3 Creative Diagnostic Antibiotic Resistance Biomarkers Products, Services and Solutions
7.8.4 Creative Diagnostic Antibiotic Resistance Biomarkers Revenue (US$ Million) & (2019-2024)
7.8.5 Creative Diagnostic Recent Developments
7.9 Roche
7.9.1 Roche Profile
7.9.2 Roche Main Business
7.9.3 Roche Antibiotic Resistance Biomarkers Products, Services and Solutions
7.9.4 Roche Antibiotic Resistance Biomarkers Revenue (US$ Million) & (2019-2024)
7.9.5 Roche Recent Developments
7.10 HiMedia Laboratories
7.10.1 HiMedia Laboratories Profile
7.10.2 HiMedia Laboratories Main Business
7.10.3 HiMedia Laboratories Antibiotic Resistance Biomarkers Products, Services and Solutions
7.10.4 HiMedia Laboratories Antibiotic Resistance Biomarkers Revenue (US$ Million) & (2019-2024)
7.10.5 HiMedia Laboratories Recent Developments
7.11 Danaher Corporatory
7.11.1 Danaher Corporatory Profile
7.11.2 Danaher Corporatory Main Business
7.11.3 Danaher Corporatory Antibiotic Resistance Biomarkers Products, Services and Solutions
7.11.4 Danaher Corporatory Antibiotic Resistance Biomarkers Revenue (US$ Million) & (2019-2024)
7.11.5 Danaher Corporatory Recent Developments
8 Industry Chain Analysis
8.1 Antibiotic Resistance Biomarkers Industrial Chain
8.2 Antibiotic Resistance Biomarkers Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Antibiotic Resistance Biomarkers Sales Model
8.5.2 Sales Channel
8.5.3 Antibiotic Resistance Biomarkers Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Thermo Fisher Scientific
Qiagen NV
Abbott
Bio Rad Laboratories
Cube Dx GmbH
Merck
Creative Diagnostic
Roche
HiMedia Laboratories
Danaher Corporatory
GenMark Diagnostic
List of Tables
    Table 1. Antibiotic Resistance Biomarkers Market Trends
    Table 2. Antibiotic Resistance Biomarkers Market Drivers & Opportunity
    Table 3. Antibiotic Resistance Biomarkers Market Challenges
    Table 4. Antibiotic Resistance Biomarkers Market Restraints
    Table 5. Global Antibiotic Resistance Biomarkers Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Antibiotic Resistance Biomarkers Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Antibiotic Resistance Biomarkers Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Antibiotic Resistance Biomarkers Product Type
    Table 9. Key Companies Time to Begin Mass Production of Antibiotic Resistance Biomarkers
    Table 10. Global Antibiotic Resistance Biomarkers Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibiotic Resistance Biomarkers as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Antibiotic Resistance Biomarkers Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Antibiotic Resistance Biomarkers Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Antibiotic Resistance Biomarkers Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Antibiotic Resistance Biomarkers Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Antibiotic Resistance Biomarkers Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Antibiotic Resistance Biomarkers Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Antibiotic Resistance Biomarkers Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Antibiotic Resistance Biomarkers Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Antibiotic Resistance Biomarkers Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Antibiotic Resistance Biomarkers Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Antibiotic Resistance Biomarkers Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Antibiotic Resistance Biomarkers Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Antibiotic Resistance Biomarkers Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Antibiotic Resistance Biomarkers Sales Value by Region (2019-2024) & (%)
    Table 27. Global Antibiotic Resistance Biomarkers Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Antibiotic Resistance Biomarkers Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Antibiotic Resistance Biomarkers Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Antibiotic Resistance Biomarkers Sales Value, (2025-2030) & (US$ Million)
    Table 31. Thermo Fisher Scientific Basic Information List
    Table 32. Thermo Fisher Scientific Description and Business Overview
    Table 33. Thermo Fisher Scientific Antibiotic Resistance Biomarkers Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Antibiotic Resistance Biomarkers Business of Thermo Fisher Scientific (2019-2024)
    Table 35. Thermo Fisher Scientific Recent Developments
    Table 36. Qiagen Basic Information List
    Table 37. Qiagen Description and Business Overview
    Table 38. Qiagen Antibiotic Resistance Biomarkers Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Antibiotic Resistance Biomarkers Business of Qiagen (2019-2024)
    Table 40. Qiagen Recent Developments
    Table 41. Abbott Basic Information List
    Table 42. Abbott Description and Business Overview
    Table 43. Abbott Antibiotic Resistance Biomarkers Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Antibiotic Resistance Biomarkers Business of Abbott (2019-2024)
    Table 45. Abbott Recent Developments
    Table 46. Bio-Rad Laboratories Basic Information List
    Table 47. Bio-Rad Laboratories Description and Business Overview
    Table 48. Bio-Rad Laboratories Antibiotic Resistance Biomarkers Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Antibiotic Resistance Biomarkers Business of Bio-Rad Laboratories (2019-2024)
    Table 50. Bio-Rad Laboratories Recent Developments
    Table 51. Cube Dx GmbH Basic Information List
    Table 52. Cube Dx GmbH Description and Business Overview
    Table 53. Cube Dx GmbH Antibiotic Resistance Biomarkers Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Antibiotic Resistance Biomarkers Business of Cube Dx GmbH (2019-2024)
    Table 55. Cube Dx GmbH Recent Developments
    Table 56. GenMark Diagnostic Basic Information List
    Table 57. GenMark Diagnostic Description and Business Overview
    Table 58. GenMark Diagnostic Antibiotic Resistance Biomarkers Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Antibiotic Resistance Biomarkers Business of GenMark Diagnostic (2019-2024)
    Table 60. GenMark Diagnostic Recent Developments
    Table 61. Merck Basic Information List
    Table 62. Merck Description and Business Overview
    Table 63. Merck Antibiotic Resistance Biomarkers Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Antibiotic Resistance Biomarkers Business of Merck (2019-2024)
    Table 65. Merck Recent Developments
    Table 66. Creative Diagnostic Basic Information List
    Table 67. Creative Diagnostic Description and Business Overview
    Table 68. Creative Diagnostic Antibiotic Resistance Biomarkers Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Antibiotic Resistance Biomarkers Business of Creative Diagnostic (2019-2024)
    Table 70. Creative Diagnostic Recent Developments
    Table 71. Roche Basic Information List
    Table 72. Roche Description and Business Overview
    Table 73. Roche Antibiotic Resistance Biomarkers Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Antibiotic Resistance Biomarkers Business of Roche (2019-2024)
    Table 75. Roche Recent Developments
    Table 76. HiMedia Laboratories Basic Information List
    Table 77. HiMedia Laboratories Description and Business Overview
    Table 78. HiMedia Laboratories Antibiotic Resistance Biomarkers Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Antibiotic Resistance Biomarkers Business of HiMedia Laboratories (2019-2024)
    Table 80. HiMedia Laboratories Recent Developments
    Table 81. Danaher Corporatory Basic Information List
    Table 82. Danaher Corporatory Description and Business Overview
    Table 83. Danaher Corporatory Antibiotic Resistance Biomarkers Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Antibiotic Resistance Biomarkers Business of Danaher Corporatory (2019-2024)
    Table 85. Danaher Corporatory Recent Developments
    Table 86. Key Raw Materials Lists
    Table 87. Raw Materials Key Suppliers Lists
    Table 88. Antibiotic Resistance Biomarkers Downstream Customers
    Table 89. Antibiotic Resistance Biomarkers Distributors List
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
    Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Antibiotic Resistance Biomarkers Product Picture
    Figure 2. Global Antibiotic Resistance Biomarkers Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Antibiotic Resistance Biomarkers Sales Value (2019-2030) & (US$ Million)
    Figure 4. Antibiotic Resistance Biomarkers Report Years Considered
    Figure 5. Global Antibiotic Resistance Biomarkers Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Antibiotic Resistance Biomarkers Revenue in 2023
    Figure 7. Antibiotic Resistance Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Blood Biomarkers Picture
    Figure 9. Urine Biomarkers Picture
    Figure 10. Global Antibiotic Resistance Biomarkers Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Antibiotic Resistance Biomarkers Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Diagnostics
    Figure 13. Product Picture of Drug Discovery
    Figure 14. Product Picture of Personalized Medicine
    Figure 15. Product Picture of Others
    Figure 16. Global Antibiotic Resistance Biomarkers Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Antibiotic Resistance Biomarkers Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Antibiotic Resistance Biomarkers Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Antibiotic Resistance Biomarkers Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Antibiotic Resistance Biomarkers Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Antibiotic Resistance Biomarkers Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Antibiotic Resistance Biomarkers Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Antibiotic Resistance Biomarkers Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Antibiotic Resistance Biomarkers Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Antibiotic Resistance Biomarkers Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Antibiotic Resistance Biomarkers Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Antibiotic Resistance Biomarkers Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Antibiotic Resistance Biomarkers Sales Value (%), (2019-2030)
    Figure 29. United States Antibiotic Resistance Biomarkers Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Antibiotic Resistance Biomarkers Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Antibiotic Resistance Biomarkers Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Antibiotic Resistance Biomarkers Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Antibiotic Resistance Biomarkers Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Antibiotic Resistance Biomarkers Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Antibiotic Resistance Biomarkers Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Antibiotic Resistance Biomarkers Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Antibiotic Resistance Biomarkers Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Antibiotic Resistance Biomarkers Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Antibiotic Resistance Biomarkers Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Antibiotic Resistance Biomarkers Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Antibiotic Resistance Biomarkers Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Antibiotic Resistance Biomarkers Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Antibiotic Resistance Biomarkers Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Antibiotic Resistance Biomarkers Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Antibiotic Resistance Biomarkers Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Antibiotic Resistance Biomarkers Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Antibiotic Resistance Biomarkers Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Antibiotic Resistance Biomarkers Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Antibiotic Resistance Biomarkers Sales Value by Application (%), 2023 VS 2030
    Figure 50. Antibiotic Resistance Biomarkers Industrial Chain
    Figure 51. Antibiotic Resistance Biomarkers Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Antibacterial Drug Resistance Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pets Antibiotic Treatment Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antibiotic Resistance Market Insights Forecast to 2030
MRSA Antibiotics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pediatric Antibiotics Market Research Report 2024
Antimicrobial Susceptibility Test Market
Antibiotic Resistance Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antibiotics Active Pharmaceutical Ingredient API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cephalosporin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Multidrug Resistant Bacteria Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cephalosporin Antibiotics API Market Research Report 2025
Antibiotic Susceptibility Testing Market
Anti Microbial Resistance Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Animal Antibiotics Antimicrobials Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antimicrobial Resistance Surveillance Market Research Report 2024
Global Antibiotic Stewardship Biomarkers Market Research Report 2024
Global Systemic Antibiotics Market Research Report 2024
Sepsis Biomarkers Market
Global Biomarker Detection Systems Market Research Report 2024
Global Ceftazidime Market Insights Forecast to 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions